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0022-2836/$ - see front matter © 2009 EParkinson's disease (PD) is associated with the deposition of fibrillar
aggregates of the protein α-synuclein (αS) in neurons. Intramolecular
contacts between the acidic C-terminal tail of αS and its N-terminal region
have been proposed to regulate αS aggregation, and two originally
described PD mutations, A30P and A53T, reportedly reduce such contacts.
We find that the most recently discovered PD-linked αS mutation E46K,
which also accelerates the aggregation of the protein, does not interfere with
C-terminal-to-N-terminal contacts and instead enhances such contacts.
Furthermore, we do not observe a substantial reduction in such contacts in
the two previously characterized mutants. Our results suggest that C-
terminal-to-N-terminal contacts in αS are not strongly protective against
aggregation, and that the dominant mechanism by which PD-linked
mutations facilitate αS aggregation may be altering the physicochemical
properties of the protein such as net charge (E46K) and secondary structure
propensity (A30P and A53T).Edited by S. Radford Keywords: synuclein; Parkinson's; amyloid; protein aggregation; E46KIntroduction
α-Synuclein (αS) is a small 140-amino-acid
protein that is intrinsically unstructured in aqueous
solution and is enriched in vivo in the presynaptic
terminals of the central nervous system.1 Amyloid
fibril aggregates of αS constitute a major compo-
nent of characteristic proteinacious deposits formed
in Parkinson's disease (PD) brains,2,3 suggesting
that αS aggregation may play a central role in the
development of PD. Although the majority of PD
cases appear to be sporadic, duplication or triplica-
tion of the αS gene4,5 or the presence of any of three
missense mutations A30P,6 E46K,7 and A53T8 is
associated with hereditary PD. The physiological
functions of αS remain unclear, but various
studies suggest roles of αS in modulating synapticess:
n's disease; αS, α-
tion enhancement;
ar coupling; HSQC,
ence; NIH, National
lsevier Ltd. All rights reserveplasticity,9 presynaptic vesicle pool size, and neuro-
transmitter release.10–12
Structurally, αS in its free state shows a weak
propensity for helical structure throughout the N-
terminal lipid-binding domain and a preference for
more extended conformations in the acidic C-
terminal tail region.13 The PD-linked αS mutations
A30P and A53T lead to a local decrease in the helical
propensity of the protein—an effect that has been
proposed to play a role in facilitating the aggregation
of these two mutants into the β-sheet-rich amyloid
fibril state.14 The presence of amphipathic helical
structure, combined with the known role of the
hydrophobic NAC region of αS in mediating inter-
molecular interactions, also led to the hypothesis that
transient long-range intramolecular contacts could
protect αS from aggregation.14 NMR paramagnetic
relaxation enhancement (PRE) measurements con-
firmed the presence of long-range contacts in αS, but
these were observed predominantly between the
acidic C-terminal tail and both the NAC region and a
region near the N-terminus of the protein.15,16 A
subsequent report indicated that the A30P and A53T
mutations disrupt these long-range interactions, and
this effect was proposed to underlie the ability of
these mutants to facilitate αS aggregation in vitro.17d.
1023E46K Enhances Contacts in SynucleinHere we report a detailed NMR structural study of
the most recently discovered PD-linked αS mutation
E46K. Previous work has shown that this mutant
also increases the rate of αS aggregation in vitro and
in situ,18–20 suggesting that it also may result in the
disruption of protective intramolecular long-range
interactions. Surprisingly, we find that the E46K
mutation does not decrease the interaction of the
C-terminal tail of αS with either the NAC or the
N-terminal regions of the protein and instead
enhances these interactions. Furthermore, a com-
parison of all three PD-linked mutants with the
wild-type (WT) protein indicates that none of the
mutations abrogates these long-range contacts,
suggesting that intramolecular contacts involving
the C-terminal tail are unlikely to play a dominant
role in regulating the aggregation rate of αS.Results
Paramagnetic relaxation enhancement
PRE results from the dipolar interaction between
the magnetic moments of a proton and an unpaired
electron and is readily detectable up to distances of
∼25 Å,21,22 providing a sensitive tool for detecting
long-range interactions in proteins. We measured
PRE effects in E46K αS using spin labels conjugated
to cysteine mutants S9C, E20C, S42C, H50C, A85C,
E110C, P120C, and A140C in the E46K background.
To allow a direct comparison with the WT protein,
we augmented previously obtained data with data
on S42C and H50C mutants with WT background.
To provide a comparison with the two other PD-
linked mutations A30P and A53T, we measured
corresponding PRE data for both of these mutants.
Figure 1 shows a comparison of PRE effects
between the WT and all three PD-linked mutants.
As expected, spin-label positions near the N-terminus
of the protein (S9 and E20) lead to significant
broadening in the C-terminal tail of WT αS (Fig.
1a), and a spin label positioned in the C-terminal tail
(P120) leads to broadening at the N-terminus. C-
terminal labeling also leads to broadening in the
NAC region of the protein, and labels in the NAC
region (A85) lead to broadening in the C-terminal
tail. These observations recapitulate previous
studies15,16,23 demonstrating contacts between the
C-terminal tail of WT αS and the NAC and N-
terminal regions. Interestingly, all spin-label posi-
tions within the lipid-binding domain of αS
(residues ∼1–100) led to a local broadening pattern
that was significantly more extensive than that
predicted based on a statistical model for anFig. 1. PRE data for (a) αSWT, (b) αS E46K, (c) αS A30P, and
peaks that are well-resolved in 1H–15N HSQC spectra. Red cu
random-coil model. Green curves represent a seven-residue m
provided to facilitate a comparison of mutant and WT da
previously23 and are included for purposes of comparison.idealized Gaussian random-coil polypeptide. In
addition, spin labels at previously unexamined
positions (S42 and H50) indicated that this region
of αS also interacts strongly with both the NAC
region and the C-terminal tail of the protein.
Data for the E46K mutant (Fig. 1b) show the same
features apparent for the WT, with spin labels at N-
terminal positions 9 and 20 leading to significant
broadening for residues 110–140 in the C-terminal
tail, with labeling at position 85 leading to broad-
ening for residues 100–120, and with a label at
position 120 leading to broadening both at N-
terminal residues 3–20 and at NAC region residues
75–95. Compared with the WT data, the long-range
broadening effects appear to be somewhat more
pronounced for the E46K mutant, and this is
especially true for labels at the S42 andH50 positions.
Given that the E46K mutant was not observed to
reduce long-range PRE compared to WT αS, we
decided to examine the two remaining PD-linked
mutants A30P (Fig. 1c) and A53T (Fig. 1d). Both
mutants, like E46K, continue to exhibit broadening
patterns similar to those observed for the WT
protein. In particular, broadening effects associated
with spin labeling at positions 20, 85, and 120, which
most clearly illustrate interactions between the C-
terminal tail and the N-terminal and NAC regions,
are very similar to those observed for theWT protein.
Residual dipolar couplings
Residual dipolar couplings (RDCs) have become a
useful tool in elucidating protein structures and
dynamics, not only in proteins with a well-defined
structure but also in disordered protein states.24–27
Recent reports have suggested that RDCs in αS may
reflect the presence of long-range contacts,16,28 and
that changes in the RDC profiles of PD-linked αS
mutants reflect a decrease in such contacts.17 We
measured RDCs from E46K αS, as well as from the
WT and A30P and A53T mutants, in order to
compare all four variants. We also measured RDCs
for a C-terminal fragment of αS (residues 103–140).
For bicelle-aligned WT αS, several distinct fea-
tures are observed in the RDC data. Negative RDCs
are observed for the N-terminal 10 residues, and
positive but small RDCs are observed for residues
20–50. The remainder of the lipid-binding domain
exhibits positive RDCs, with notable dips around
positions 68 and 85. The C-terminal tail region
exhibits two lobes of large positive RDCs separated
by a dip around position 120, as previously
reported.16 Elimination of these C-terminal lobes in
the presence of the PD-linked mutations A30P and
A53T, as well as in the presence of polycations or
protein denaturants, led to the conclusion that this(d) αS A53T. Histograms show the intensity ratio for those
rves represent the broadening expected from a theoretical
oving average of the data from the WT protein and are
ta. Some data for the WT protein have been reported
Fig. 1 (legend on previous page)
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WT protein that are eliminated in the presence of
PD-linked mutations.16,17
Surprisingly, RDC data for the bicelle-aligned
E46K mutant appeared highly similar to those
obtained for the WT protein. In particular, the
double-lobed feature in the C-terminal tail of the
protein was completely preserved. Given this
unexpected result, we proceeded to examine the
remaining two PD-linked mutations, A30P and
A53T. In both cases, we obtained RDC data that
were highly similar to both WT and E46K data, and
again the double-lobed feature in the C-terminal tail
of the protein was preserved.
To further investigate whether the double-lobed
feature in the C-terminal tail of αS might result from
long-range interactions, we prepared a fragment of
the protein consisting of residues 103–140 and
measured RDCs from this fragment aligned in a
bicelle medium. The data (Fig. 2a) reveal that the
RDC values for the isolated C-terminal tail fragment
overlay the data for the corresponding residues in
the intact full-length protein quite well, demonstrat-
ing that the remainder of the protein is not involved
in determining the pattern of RDC values in the C-
terminal tail of αS.
Residual secondary structure
To assess the influence of the E46K mutation on
residual secondary structure in αS, we calculated theFig. 2. RDCs for (a) αS WT, (b) αS E46K, (c) αS A30P, and
(residues 103–140) in bicelles are overlaid on the correspond
inverted according to convention.deviations of the observed Cα chemical shifts from
values expected for peptides without secondary
structure preferences (so-called secondary Cα shifts).
Positive deviations are expected for regions prefer-
ring helical regions of ϕ,ψ space, while negative
values are indicative of a preference for extended
structures. The data indicate that there are few
differences between the secondary shifts observed
for the E46K mutant and those previously reported
for the WT protein.13 Immediately adjacent to the
site of the mutation, a few residues exhibit a change
from negative secondary shifts to positive values,
indicating a slight increase in local helix propensity.Discussion
αS forms amyloid fibrils found in Lewy bodies, a
hallmark of the neurodegenerative disorder PD.29
The formation of fibrils is thought to be a stepwise
process in which αS goes through conformational
changes, followed by oligomerization and, finally,
assembly into mature fibrils.30 Conformational tran-
sitions that modulate initial aggregation steps lead-
ing to oligomer formation are likely to be particularly
crucial because the clearest common effect of all three
PD-linked αS mutations is to increase the protein's
oligomerization rate,7,31 suggesting that oligomeric
states may be the toxic species involved in the
pathogenesis of PD. Although it seems likely that the
PD-linked αS mutations influence the aggregation(d) αS A53T in bicelles. RDCs for the C-terminal tail of αS
ing plot for αS WT (a) in red. Note that the RDC sign is
1027E46K Enhances Contacts in Synucleinrate of the protein by altering its physicochemical
and/or structural properties, a precise understanding
of their effects remains elusive.
Previous structural models of how PD mutations
influence αS aggregation
αS has been categorized as a natively unfolded or
intrinsically unstructured protein in aqueous
solution.32 Initial analysis of the conformational
preferences of the WT protein indicated that αS has
a weak preference for a helical structure distributed
throughout the N-terminal lipid-binding domain of
the protein, while the C-terminal tail has a pre-
ference for a more extended structure.13 Similar
studies performed on A30P and A53T showed that
those two mutations lead to a local decrease in
helical preference, leading to one model in which the
mutations enhance the conversion of αS into the β-
sheet-rich fibrillar conformation by destabilizing the
natural preference of the protein for its native helical
structure, which is fully materialized in the lipid-
bound state.14 An alternative model proposed that
amphipathic helical motifs could interact intramo-
lecularly with the hydrophobic NAC region of the
protein and thereby decrease intermolecular hydro-
phobic interactions that lead to αS aggregation. In
this model, disruption of amphipathic helix forma-
tion by PD-linked mutations would decrease pro-
tective intramolecular interactions and thereby
accelerate αS aggregation.14 Subsequent data
showed that long-range intramolecular interactions
do, in fact, exist in αS but involve the acidic C-
terminal tail of the protein, which interacts with the
N-terminal and NAC regions.15,16 It was further
reported that the two known (at that time) PD-
linked mutations A30P and A53T perturbed long-
range contacts involving the C-terminal tail in WT
αS,17 leading to broad acceptance of the idea that
perturbation of such contacts may be an important
mechanism by which mutations increase the aggre-
gation propensity of αS.
E46K mutation enhances long-range
interactions in αS
To investigate the potential effects of the most
recently discovered PD-linked αS mutation E46K on
long-range contacts within αS, we first evaluated
such contacts by examining PRE effects, which
reflect a spatial proximity of ∼25 Å or less between
a given residue and the location of a covalently
attached spin label. This method was originally used
to document long-range contacts in WT αS.15,16
According to the PRE data, there is no decrease in
long-range contacts in the E46K mutant relative to
that in the WT protein (Fig. 1a and b). Instead, the
data suggest an increased interaction between the C-
terminal tail and the NAC and N-terminal regions,
as well as previously unnoted interactions between
the region around residues 40–50 and both the C-
terminal and the NAC regions of the protein.
Notably, these results are in agreement with theprevious observation that E46K αS elutes slightly
later than the WT protein during size-exclusion
chromatography, suggesting that it is somewhat
more compact.33
We further examined PRE data from the A30P and
A53T PD-linked αSmutants for indications that they
perturb long-range interactions (Fig. 1c and d). Data
for both mutants closely resemble those for the WT
protein. Thus, as monitored by PRE data, long-range
interactions persist in both E46K and the two other
PD-linked αS mutations. Previously, it was reported
that the A30P and A53T mutations led to a slight
decrease in long-range PRE effects in αS.17 How-
ever, the reported decrease was likely within the
range of experimental error, and the extent of the
reduction was minor, leading to the same conclusion
drawn from our own data, namely, that long-range
contacts, as monitored by PRE data, persist for both
PD-linked mutants. A recent study of transglutami-
nase-induced αS cross-linking also suggests that
long-range contacts in WT αS are not perturbed by
the A30P and A53T mutations.34
Indeed, rather than PRE data, changes in RDCs in
the C-terminal region of αS in the presence of the
A30P and A53T mutations were the primary basis
for concluding that these mutations perturb long-
range interactions within the protein.17 Therefore,
we examined the effects of the E46K mutation on αS
RDC data (Fig. 2). Surprisingly, we found that the
E46K mutation does not substantially alter the
pattern of RDC values observed in the C-terminal
tail of αS or, for that matter, in the remainder of the
protein. Thus, RDCs do not indicate any reduction
in long-range structure between E46K and WT αS.
Because of this unexpected result, we decided to
obtain RDC data for the A30P and A53T mutants, as
well, for purposes of comparison. We were again
surprised to observe that the pattern of RDCs in the
C-terminal tail, as well as in the rest of the protein,
closely resembles that of the WT protein for both of
these mutants, providing no indication for changes
in long-range structure.
RDCs in the C-terminal tail of αS do not originate
from long-range interactions
Recently, we reported structural studies of the two
other human synuclein family members β-synuclein
and γ-synuclein.23 These studies showed that these
proteins largely lack the long-range contacts present
in αS based on PRE data, yet do show, like αS, large
RDC values in their C-terminal tails. Based on these
observations, we suggested23,35 that the RDCs in the
C-terminal tail of αS may not be a result of long-
range interactions within the protein, as had been
previously concluded.28 Instead, we observed a
qualitative correlation between the RDCs and α-
carbon secondary shifts, suggesting that the RDC
patterns may arise as a result of local secondary
structure preference, as has been noted previously.26
Here, we fail to observe changes to RDCs in the C-
terminal tail of αS in the presence of any of the three
PD-linked mutations, suggesting either that the
1028 E46K Enhances Contacts in Synucleinmutations do not perturb a long-range structure or
that the RDCs do not reflect a long-range structure,
or both. To further test whether RDCs in the C-
terminal tail of αS arise from long-range interactions,
we generated a C-terminal fragment of the protein
and recorded RDCs for this isolated fragment. The
results (Fig. 2a) clearly show that the pattern of
RDCs in the C-terminal tail of the intact protein is
closely preserved in the isolated C-terminal frag-
ment, indicating that the observed RDCs do not
result from long-range intramolecular interactions.
Role of the acidic C-terminal tail in
αS aggregation
A model in which long-range intramolecular
contacts within αS are protective is appealing
because it has a direct analogy in well-structured
proteins, which bury hydrophobic cores through a
long-range tertiary structure and thereby avoid
nonspecific protein–protein interactions and aggre-
gation. In turn, the perturbation of such interactions
by mutations in αS could facilitate aggregation in a
manner analogous to destabilizing mutations in
native proteins, causing exposure of hydrophobic
patches leading to aggregation. The data we present
here, however, suggest that the mechanism by
which PD-linked mutations facilitate αS aggregation
does not primarily involve the release of contacts
between the C-terminal tail and the N-terminal
regions of the protein. Indeed, for the A30P and
A53T mutations, these contacts appear essentially
unperturbed; for the more recently identified E46K
mutation, these contacts appear to be enhanced.
Additional evidence arguing against a protective
role for C-terminal-to-N-terminal contacts in αS is
provided by a recent study of αS phosphorylation at
Ser129.36 Phosphorylation at this site is shown to
release the C-terminus from its interactions with N-
terminal regions, yet, at the same time, to signifi-
cantly inhibit αS aggregation.
That the C-terminal tail plays any role at all in αS
aggregation is firmly established by data demon-
strating that C-terminally truncated forms of αS
aggregate more readily than the WT protein.37–39
Thus, the C-terminus appears to play a protective
role, but how is this role effected? The most
remarkable property of the C-terminal tail of αS is
its acidic nature. It contains 14 negatively charged
side chains and no positive charges past position 102.
Such a highly charged polypeptide segment can be
expected to lead to significant electrostatic self-
repulsion and to greatly increase the solubility of
any attached protein sequence. Thus, electrostatics
alone may be sufficient to explain the protective
effects of the αS C-terminal tail and why its
truncation greatly increases αS aggregation.1 Under
this model, increasing the negative charge of the C-
terminal tail through phosphorylation at Ser129
would clearly be expected to increase solubility
and to decrease aggregation, as observed.36
Simple electrostatics can also readily explain the
long-range interactions of the C-terminal tail of αSwith the remainder of the protein (i.e., the N-
terminal domain). The N-terminal lipid-binding
domain of αS contains many basic residues (a net
charge of +6 at neutral pH), which are necessary for
the interaction of the protein with negatively
charged phospholipids.40 Thus, it is not surprising
that the oppositely charged N-terminal and C-
terminal regions of the protein would form intra-
molecular interactions. Such interactions could
effectively neutralize some of the negative charges
of the C-terminal tail, but a net charge of −9 remains,
leading to significant intermolecular electrostatic
repulsion. Truncation of the C-terminal tail leaves a
lesser net charge of +5, with accordingly reduced
repulsion and increased aggregation. Addition of
polycations41 or metal ions42 can also neutralize the
negative charge of the C-terminal tail, leading to its
release from long-range interactions. However,
enhanced aggregation in the presence of polycations
or metal ions likely results from the reduction in the
net effective charge of the protein,43,44 rather than
from the release of the C-terminal tail. Similarly, a
recent study demonstrates that high salt concentra-
tions also decrease C-terminal-to-N-terminal con-
tacts in αS, indicating a significant electrostatic
component.45 Again, however, increased aggrega-
tion of αS at high ionic strength46 can primarily be
attributed to the reduction in intermolecular electro-
static repulsion by the same charge screening effect
that leads to the observed incidental decrease in C-
terminal-to-N-terminal contacts. Our current data
provide further corroboration. The E46K mutation
of αS increases the positive charge of the N-terminal
lipid-binding domain, which would be expected to
enhance interactions with the negatively charged C-
terminal domain, as we indeed observed. Further-
more, the most clearly increased interactions
involved locations near the site of the mutation (as
indicated by greatly increased PRE effects with
labels at positions 42 and 50). In contrast, the two
other PD-linked mutations A30P and A53T do not
alter the charge of the lipid-binding domain of the
protein and, in turn, do not appear to influence its
interactions with the C-terminal tail.
Mechanism by which PD-linked mutations
influence αS aggregation
Since PD-linked mutations do not substantially
reduce long-range contacts involving the C-terminal
tail of αS, how do they enhance αS aggregation?
Despite the appeal of our original model invoking
effects on long-range contacts, the alternative model
in which local changes in the physicochemical
properties of the polypeptide dominate appears, at
present, to be most consistent with the available
data. Firstly, both A30P and A53T mutations have
been shown experimentally to reduce local helical
propensity, as would be expected based on the
natural secondary structure propensities of alanine,
threonine, and proline. Unlike the first two muta-
tions, the E46K mutation increases, albeit slightly,
the local helix propensity of the protein (Fig. 3),
Fig. 3. Cα secondary shifts for αS E46K in the free state as a function of residue number (black bars) overlaid with the
Cα values previously reported for WT αS (red line).13 Positive values indicate a propensity for helical structure, while
negative values indicate a preference for strand-like structure.
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aggregation, but this mutation also decreases the net
charge of the protein by 2, an effect that could be
expected to counteract and apparently dominate a
local increase in helicity. Another example consistent
with this argument is the case of mouse αS. The
mouse protein aggregates more readily than WT αS,
and recent NMR studies have indicated that this
variant exhibits reduced C-terminal-to-N-terminal
contacts.47 The reduced contacts may be ascribed to
the elimination of one negative charge (D121) in the
C-terminal tail of mouse αS. The increased aggrega-
tion rate, however, rather than being associated with
the partial release of the C-terminal tail, likely results
from the reduction in the net charge of the protein,
as well as from two further sequence changes (A53T
and S87N), which would engender an increased
local preference for β-strand structure. Further
support for the importance of changes in physico-
chemical properties in protein aggregation is pro-
vided by recent work showing that changes in
secondary structure propensity, charge, and hydro-
phobicity can quantitatively account for the effects
of mutations on the fibrillization rates of many
amyloid-forming proteins.48 Indeed, a recent study
employed just such an algorithm to successfully
predict the expected aggregation rates of β-synu-
clein, a close homologue of αS, as well as a number
of αS variants that incorporate β-synuclein sequence
changes.49 Since this algorithm succeeds by relying
purely on the physicochemical properties of the
individual amino acid sequences and does not
include any consideration of long-range contacts
with the C-terminal tail, it can be concluded that the
former plays the dominant role in determining the
aggregation rate of αS.Conclusions
A current paradigm showing how αS aggrega-
tion is enhanced in PD invokes a protective role for
long-range interactions between the C-terminal
domain and the N-terminal domain of the protein,
which are perturbed by PD-linked mutations or byexternal factors such as polycation binding. Our
results indicate that the E46K PD-linked αS
mutation, despite enhancing αS aggregation, does
not perturb C-terminal-to-N-terminal contacts in
the protein and instead enhances such contacts. In
light of this counterexample, this paradigm cannot
be considered general. Furthermore, closer exam-
ination indicates that other PD-linked αS mutations
do not substantially reduce C-terminal-to-N-term-
inal contacts either. In place of the existing
paradigm, we suggest an alternative model in
which the C-terminal tail inhibits αS aggregation
primarily because of the net negative charge that it
lends to the intact protein. The C-terminal tail does
indeed interact with the oppositely charged N-
terminal lipid-binding domain, but these interac-
tions do not exert a dominant regulatory effect on
αS aggregation. Instead, any reduction in the net
charge of the protein, either through truncation of
the C-terminal tail or through sequence changes
associated with disease (e.g., E46K in PD) or with
divergent evolution (e.g., D121G in mouse αS),
leads to enhanced aggregation. Mutations that do
not alter net charge can apparently influence
aggregation by altering the secondary structure
preferences of the polypeptide chain (e.g., A30P
and A53T in PD) or possibly by altering the
hydrophobicity of the protein as well. This model
is consistent with recent studies highlighting the
importance of the physicochemical properties of
protein sequences in determining their propensity
to form amyloid aggregates.Materials and Methods
Protein expression and purification
αS mutants were generated using site-directed muta-
genesis of the WT plasmid construct (kindly provided by
Dr. Peter Lansbury, Harvard Medical School) and
expressed in Escherichia coli BL21(DE3) cells. Recombinant
proteins were uniformly labeled by growing cells in M9
minimal media supplemented with [13C]glucose and/or
[15N]ammonium chloride at 37 °C to an OD600 of ∼0.6,
1030 E46K Enhances Contacts in Synucleinfollowed by induction with 1 mM IPTG. Cells were
harvested 4 h after induction, followed by purification of
the protein using previously reported protocols.13
Preparation of αS C-terminal fragment
WT αS was dissolved in 50 mM Tris and 150 mM NaCl
(pH 7.6) and subjected to limited proteolysis using an αS/
trypsin (Promega) mass ratio of 100:1 at 37 °C for 24 h.34
Reactions were quenched by lowering the sample's pH to
∼3.0 using trifluoroacetic acid and stored at −20 °C.
Defrosted samples were restored to neutral pH, and the
resulting fragments, including the intact C-terminal tail
(residues 103–140), were separated using size-exclusion
chromatography (Superdex 75HR 10/30 column; GE
Healthcare) in 50 mM ammonium bicarbonate (pH 7.5),
followed by anion-exchange chromatography. Final frac-
tions were pooled, desalted, and lyophilized for storage.
NMR spectroscopy
Free-state samples were prepared by directly dissolving
lyophilized protein in 100 mMNaCl and 10 mMNa2HPO4
(pH 7.4; phosphate-buffered saline) in 90%/10% H2O/
D2O, followed by removal of any large-scale aggregate
using Microcon YM-100 centrifugal filters (Millipore).
NMR experiments were performed on either a 600-MHz
Varian INOVA spectrometer (Weill Cornell Medical
College) or 800- or 900-MHz Bruker AVANCE spectro-
meters (New York Structural Biology Center) at a sample
temperature of 10 °C. Resonance assignments for αS E46K
in the free state were based on HNCACB/CBCACONH
and HNCACO/HNCO triple-resonance experiments. All
NMR data were processed with NMRPipe50 and analyzed
using NMRView.51 Spectra were referenced indirectly to
2,2-dimethyl-2-silapentane-5-sulfonate and ammonia52
using the known chemical shift of water. Random-coil
values obtained from linear hexapeptides in 1 M urea
(pH 5.0) and 25 °C53 were used to calculate Cα secondary
shifts.
RDC measurements were made using two-dimensional
IPAP experiments based on heteronuclear single quantum
coherence (HSQC).54 Samples were aligned using
bicelles55 prepared with 7.4% (wt/vol) pentaethylene
glycol monooctyl ether (C8E5)/octanol (Sigma) at a
protein concentration of 140 μM. Alignment was verified
by measuring the deuterium quadrupolar splitting of the
water line.
PRE effects were measured using cysteine mutants
created through site-directed mutagenesis against WT,
A30P, E46K, and A53T backgrounds. Cysteines were
introduced at positions 9, 20, 42, 50, 85, 110, 120, and
140 in the protein sequence. The spin-label reagent 1-oxy-
2,2,5,5-tetramethyl-D-pyrroline-3-methyl-methanethiosul-
fonate (Toronto Research Chemicals) was added at a 10-
fold molar excess to protein-containing solutions, and
excess spin label was removed after a 2-h incubation at
room temperature by passing samples three times through
buffer-equilibrated spin columns packed with Sephadex
G-25 fine matrix (GE Healthcare). Control samples were
prepared by adding DTT to the 1-oxy-2,2,5,5-tetramethyl-
D-pyrroline-3-methyl-methanethiosulfonate-labeled pro-
teins to reduce the nitroxide spin label from the protein.
This approach was used instead of directly reducing the
nitroxide spin label or using a nonparamagnetic analogue
in order to control for the possibility of noncovalent and
nonspecific binding of the spin label to aromatic or other
protein residues. PRE effects were obtained as normalizedpeak heights from the HSQC spectra of matched spin-
labeled and control samples collected at 10 °C using a
protein concentration of 70 μM. Theoretical PRE curves
were calculated as previously described.23Acknowledgements
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